Literature DB >> 11715020

Kinesin-dependent movement on microtubules precedes actin-based motility of vaccinia virus.

J Rietdorf1, A Ploubidou, I Reckmann, A Holmström, F Frischknecht, M Zettl, T Zimmermann, M Way.   

Abstract

Vaccinia virus, a close relative of the causative agent of smallpox, exploits actin polymerization to enhance its cell-to-cell spread. We show that actin-based motility of vaccinia is initiated only at the plasma membrane and remains associated with it. There must therefore be another form of cytoplasmic viral transport, from the cell centre, where the virus replicates, to the periphery. Video analysis reveals that GFP-labelled intracellular enveloped virus particles (IEVs) move from their perinuclear site of assembly to the plasma membrane on microtubules. We show that the viral membrane protein A36R, which is essential for actin-based motility of vaccinia, is also involved in microtubule-mediated movement of IEVs. We further show that conventional kinesin is recruited to IEVs via the light chain TPR repeats and is required for microtubule-based motility of the virus. Vaccinia thus sequentially exploits the microtubule and actin cytoskeletons to enhance its cell-to-cell spread.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11715020     DOI: 10.1038/ncb1101-992

Source DB:  PubMed          Journal:  Nat Cell Biol        ISSN: 1465-7392            Impact factor:   28.824


  109 in total

1.  Identification of second-site mutations that enhance release and spread of vaccinia virus.

Authors:  Ehud Katz; Elizabeth Wolffe; Bernard Moss
Journal:  J Virol       Date:  2002-11       Impact factor: 5.103

2.  Direct interaction of baculovirus capsid proteins VP39 and EXON0 with kinesin-1 in insect cells determined by fluorescence resonance energy transfer-fluorescence lifetime imaging microscopy.

Authors:  John O Danquah; Stanley Botchway; Ananya Jeshtadi; Linda A King
Journal:  J Virol       Date:  2011-11-09       Impact factor: 5.103

3.  The role of the cytoskeleton in the life cycle of viruses and intracellular bacteria: tracks, motors, and polymerization machines.

Authors:  E L Bearer; P Satpute-Krishnan
Journal:  Curr Drug Targets Infect Disord       Date:  2002-09

4.  Efficient active transport of gene nanocarriers to the cell nucleus.

Authors:  Junghae Suh; Denis Wirtz; Justin Hanes
Journal:  Proc Natl Acad Sci U S A       Date:  2003-03-18       Impact factor: 11.205

5.  Mutations in the vaccinia virus A33R and B5R envelope proteins that enhance release of extracellular virions and eliminate formation of actin-containing microvilli without preventing tyrosine phosphorylation of the A36R protein.

Authors:  Ehud Katz; Brian M Ward; Andrea S Weisberg; Bernard Moss
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 6.  Discovery of antivirals against smallpox.

Authors:  Stephen C Harrison; Bruce Alberts; Ellie Ehrenfeld; Lynn Enquist; Harvey Fineberg; Steven L McKnight; Bernard Moss; Michael O'Donnell; Hidde Ploegh; Sandra L Schmid; K Peter Walter; Julie Theriot
Journal:  Proc Natl Acad Sci U S A       Date:  2004-07-12       Impact factor: 11.205

7.  Construction and characterization of a fluorescently labeled infectious human immunodeficiency virus type 1 derivative.

Authors:  Barbara Müller; Jessica Daecke; Oliver T Fackler; Matthias T Dittmar; Hanswalter Zentgraf; Hans-Georg Kräusslich
Journal:  J Virol       Date:  2004-10       Impact factor: 5.103

Review 8.  Exploitation of Cytoskeletal Networks during Early Viral Infection.

Authors:  Derek Walsh; Mojgan H Naghavi
Journal:  Trends Microbiol       Date:  2018-07-20       Impact factor: 17.079

9.  The Salmonella effector SteA contributes to the control of membrane dynamics of Salmonella-containing vacuoles.

Authors:  Lia Domingues; David W Holden; Luís Jaime Mota
Journal:  Infect Immun       Date:  2014-04-28       Impact factor: 3.441

10.  Exploitation of microtubule cytoskeleton and dynein during parvoviral traffic toward the nucleus.

Authors:  Sanna Suikkanen; Tuula Aaltonen; Marjukka Nevalainen; Outi Välilehto; Laura Lindholm; Matti Vuento; Maija Vihinen-Ranta
Journal:  J Virol       Date:  2003-10       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.